Vaccines for Adults (VFA) 2015
Awarded Award Notice Posted
- Solicitation number
- 2015-N-16902
- Agency
- CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 200-2015-62836|na
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Not on record
- Place of performance
- Conus and territories, United States
Notice details come from SAM.gov. Updated .
Notice text
3 versions
Update #3 · Latest ·
Added: Jan 07, 2016 1:31 pm
The Centers for Disease Control and Prevention, NCIRD/ISD, 1600 Clifton Rd. NE, Mailstop A19, Atlanta, GA, 30333, hereby announces its intent to issue a sole source contract to Merck Sharp & Dohme Corporation 1 Merck Drive Whitehouse Station, NJ 08889-3400 to increase the target quantities of the Zostavax vaccine.
NAICS Code: 325412
Period of Performance: 07/01/2015 to 06/30/2016
The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 13.106-1(b)(1)(i). CDC needs to modify its adult contract with Merck to expand the maximum doses available to meet increased demand of Zostavax® vaccine. CDC has no other contract with an equivalent vaccine to meet this demand.
Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency for future procurement. Please forward the capability statement and/or pricing information to Michael Harwell, Contracting Specialist, Reference 200-2015-62836, Centers for Disease Control, Office of Acquisition Services, ATTN: Michael Harwell, MS: K14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov.
This is a posting of a sole source award to Merck Sharp & Dohme and is not a request for competition.
Update #2 ·
Added: Apr 07, 2015 11:56 am This amendment adds the solicitation document.
Update #1 ·
Added: Mar 16, 2015 1:33 pm
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following pediatric vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration:
Item Descriptions & Quantities
1. Hepatitis A adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 175,000 Doses
Minimum: 100 Doses
2. Hepatitis B adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 375,000 Doses
Minimum: 100 Doses
3. Hepatitis A & B combination adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses
4. Pneumococcal Polysaccharide vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 Doses
Minimum: 100 Doses
5. Tetanus and Diphtheria Toxoids vaccine for adults
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 100,000 Doses
Minimum: 100 Doses
6. Herpes Zoster vaccine for adults
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 250,000 Doses
Minimum: 10 Doses
7. Tetanus, Reduced Diphtheria Toxoid, and Acellular Pertussis (TDaP)
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 850,000 Doses
Minimum: 100 Doses
8. Measles, Mumps, and Rubella
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses
9. Meningococcal Conjugate (Groups A,C,Y &W)
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses
10. Human Papillomavirus (Includes HPV2, HPV4, HPV9)
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 300,000 Doses
Minimum: 100 Doses
11. Varicella
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 150,000 Doses
Minimum: 10 Doses
12. PCV13
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 500,000 Doses
Minimum: 100 Doses
13. Serogroup B Meningococcal
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75
Maximum: 150,000 Doses
Minimum: 100 Doses
The vaccines awarded under these contracts will be purchased for NCIRD's immunization awardees (the fifty state health departments, several large city programs and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act. This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items. Vaccines shall be shipped F.O.B. Destination to the 50 states and U.S. territories. The period of performance shall be 12 months from 7/1/2015. Any questions regarding this notice shall be submitted in writing ONLY to Michael Harwell at wyu4@cdc.gov. Telephone inquiries will not be honored.
Attachments
| File | Type | Posted |
|---|---|---|
| 2015_VFA_Solicitation.pdf | ||
| 2015_VFA_Solicitation.doc | DOC document | |
| 2015_VFA_Solicitation.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity